Trial Details
COMPLETEDBasic Information
| Clinical ID | c1974 |
|---|---|
| Identifier | NCT04166058 |
| Trial Title | Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Irritable Bowel Syndrome With Constipation|Functional Constipation |
| Interventions | DRUG: Irritable Bowel Syndrome with Constipation (IBS-C) participants (LIN-MD-63 and LIN-MD-64 completers)|DRUG: Functional Constipation (FC) participants (LIN-MD-62 and LIN-MD-64 completers) |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2019-11-19 |
|---|---|
| Primary Completion Date | 2025-06-05 |
| Completion Date | 2025-06-05 |